Aptinyx Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Liquidation
- Investors
-
1
Aptinyx General Information
Description
Provider of clinical-stage biopharmaceutical research intended to serve patients with central nervous system disorders. The company develops small-molecule modulators of NMDA receptors to treat conditions such as chronic pain, post-traumatic stress disorder, and cognitive impairment, enabling healthcare companies with therapies that improve neurological health and patient outcomes.
Contact Information
Website
www.aptinyx.comCorporate Office
- 909 Davis Street
- Suite 600
- Evanston, IL 60201
- United States
Corporate Office
- 909 Davis Street
- Suite 600
- Evanston, IL 60201
- United States
Aptinyx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Bankruptcy: Liquidation | 23-May-2023 | Completed | Bankruptcy: Liquidation | |||
| 9. 2PO | 13-Jan-2020 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Open Market | Completed | Generating Revenue | ||||
| 7. IPO | 21-Jun-2018 | Completed | Clinical Trials - Phase 2 | |||
| 6. Early Stage VC | Completed | Clinical Trials - Phase 2 | ||||
| 5. Early Stage VC (Series B) | 18-Dec-2017 | Completed | Clinical Trials - Phase 2 | |||
| 4. Early Stage VC (Series A) | 10-May-2016 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 01-Jan-2016 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 15-Sep-2015 | Completed | Startup | |||
| 1. Spin-Off | 28-Aug-2015 | Completed | Startup |
Aptinyx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 151,772,701 | $0.010000 | $0.16 | $0.16 | 1x | $0.16 | 19.69% |
Aptinyx Comparisons
Industry
Financing
Details
Aptinyx Competitors (71)
One of Aptinyx’s 71 competitors is Neurona Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neurona Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Asceneuron | Venture Capital-Backed | Eysins, Switzerland | ||||
| NeuroNascent | Venture Capital-Backed | Clarksville, MD | ||||
| Autobahn Therapeutics | Venture Capital-Backed | San Diego, CA | ||||
| CereSpir | Venture Capital-Backed | New York, NY |
Aptinyx Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Aptinyx Patents
Aptinyx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022086858-A1 | Methods of treating post-traumatic stress disorder and related conditions | Inactive | 19-Oct-2020 | ||
| AU-2021284376-A1 | Spiro-lactam compounds and methods of treating viral infections | Inactive | 03-Jun-2020 | ||
| EP-4161517-A2 | Spiro-lactam compounds and methods of treating viral infections | Inactive | 03-Jun-2020 | ||
| WO-2021247880-A3 | Spiro-lactam compounds and methods of treating viral infections | Inactive | 03-Jun-2020 | ||
| CA-3184348-A1 | Spiro-lactam compounds and methods of treating viral infections using the same | Pending | 03-Jun-2020 | A61K31/499 |
Aptinyx Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aptinyx Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institute on Aging | Government |
Aptinyx ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Services
Subindustry
Rank
Percentile
Aptinyx FAQs
-
When was Aptinyx founded?
Aptinyx was founded in 2015.
-
Where is Aptinyx headquartered?
Aptinyx is headquartered in Evanston, IL.
-
What is the size of Aptinyx?
Aptinyx has 12 total employees.
-
What industry is Aptinyx in?
Aptinyx’s primary industry is Drug Discovery.
-
Is Aptinyx a private or public company?
Aptinyx is a Private company.
-
What is Aptinyx’s current revenue?
The current revenue for Aptinyx is .
-
How much funding has Aptinyx raised over time?
Aptinyx has raised $268M.
-
Who are Aptinyx’s investors?
National Institute on Aging has invested in Aptinyx.
-
Who are Aptinyx’s competitors?
Neurona Therapeutics, Asceneuron, NeuroNascent, Autobahn Therapeutics, and CereSpir are some of the 71 competitors of Aptinyx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
